The gastrointestinal tract is an organ of digestion and absorption which is
metabolically active and has specific nutrient requirements. In health, it
has an additional function as a major barrier, protecting the body from ha
rmful intraluminal pathogens and large antigenic molecules. In disease stat
es, such as sepsis when the mucosal barrier is compromised, micro-organisms
and their toxic products gain access to the portal and systemic circulatio
ns producing deleterious effects. Under these circumstances, systemic infla
mmatory response syndrome (SIRS) and multiple organ dysfunction syndrome (M
ODS) develop leading to deterioration and death of the patient in the inten
sive care unit. Therapeutic strategies for such patients in the intensive c
are unit aim to support general immune function and maintain the structure
and function of the gastrointestinal tract. For these therapies to be succe
ssful, the underlying septic or necrotic focus must be ablated using approp
riate surgical or other invasive techniques.